February 2, 2012 -- YARDLEY, Pa. -- OptiNose Inc. announces the filing of an Investigational New Drug (IND) with the U.S. Food and Drug Administration […]
December 1, 2011 -- NEW YORK, Dec. 23, 2011 /PRNewswire/ --AaTheraBiogen, Inc. (OTC BB: TRAB), a manufacturer and distributor of homeopathic nasal spr […]
November 15, 2011 -- FDA approves Botox, or Botulinum toxin type A, the popular wrinkle relaxer and plastic surgeon office staple, to help those who s […]